Virtual Science AI has launched Virtual Advisory AI, a virtual engagement platform that delivers the most seamless advisory board engagement experiences and the first AI-driven analytics on life science advisory board activities.
Tom Hughes, CEO of Virtual Science AI, said, “As life science teams embrace hybrid work it’s an exciting time for virtual work solution providers to partner with teams to shape the ways of working with healthcare stakeholders for the better, we believe Virtual Science AI has built the next generation virtual engagement solutions that will move the needle on advisory board stakeholder experiences and insight management, Virtual Science AI is able to make sense of interactive data in ways that just have not been done before.”
“The asynchronous engagement allows the participants of the advisory boards to provide input in virtual work environments at a time suitable to their schedules. It enables the participants to engage asynchronously around their time schedule over say a 2-week period, rather than a pre-set intensive 6-hour advisory board, this evolved approach results in a higher level of engagement and higher quality deep work outputs.”
As part of its virtual engagement platform, Virtual Advisory AI, Virtual Science AI is committed to improving the engagement of pharmaceutical stakeholders with its industry. The platform offers features like synchronous and asynchronous communication, co-collaboration tools, and artificial intelligence (AI) report generation.
With the solution, stakeholders in the life sciences industry will be able to interact with healthcare workers, patient communities, and decision-makers in a compliant manner in a virtual environment without any barriers, and this will improve strategic decision-making. Using Virtual Advisory AI, a software as a service (SaaS) organization, doctors and project managers can utilize the capabilities of Virtual Science AI to run activities and generate unique insights from virtual engagement activities for a real-world impact.
